MAPT and Parkinson disease: Using the MPTP mouse neurotoxin model of PD, as well as cellular models of PD, we had previously demonstrated that increases in α-Syn can initiate and sustain Tau hyperphosphorylation both in vivo and in vitro[24]–[27].